Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05038839
Recruitment Status : Not yet recruiting
First Posted : September 9, 2021
Last Update Posted : November 23, 2021
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 3, 2024
Estimated Study Completion Date : June 3, 2024